Max Robotics — Global Service Robot Directory + US Certification

About

Dr. Carla Cappelli is a pioneering surgeon whose research has fundamentally advanced the field of robotic pancreatic surgery. Her work focuses on the feasibility and safety of robotic-assisted procedures for complex pancreatic pathologies, particularly pancreatic cancer. Dr. Cappelli’s major contributions include demonstrating that robotic pancreatoduodenectomy—a notoriously difficult operation—can be performed safely, even when vascular resection is required. Her landmark 2013 study on the feasibility of robotic pancreaticoduodenectomy (196 citations) established a critical foundation for the field, while her propensity score-matched analyses (2018, 52 citations; 2024, 11 citations) provided rigorous evidence that robotic approaches can achieve comparable oncologic outcomes to open surgery, particularly regarding margin status. She also contributed to the development of the EndoCAS navigator platform (2008, 26 citations), a common platform for computer and robotic assistance in minimally invasive surgery, showcasing her interest in surgical technology innovation. By consistently demonstrating that robotic techniques can match the oncologic rigor of open surgery while offering patients the benefits of minimally invasive recovery, Dr. Cappelli has helped reshape the standard of care for pancreatic cancer surgery.